MedPath

Study on the Brain Function Imaging Mechanism of Shu-Mu Point Catgut Embedding Intervention of Female Patients with Abdominal Obesity

Not Applicable
Conditions
abdominal obesity
Registration Number
ITMCTR2100005075
Lead Sponsor
Yunnan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for abdominal obesity (BMI 28-39.9kg/m^2, waist circumference>=80cm );
2. Females with right handedness aged between 18-40 years (including 18 and 40 years old);
3. Have a certain writing and reading ability to understand the entire process of research;
4. Signed informed consent forms;
5. No other trials were taken within three months.

Exclusion Criteria

1. Secondary obesity, such as: obesity caused by endocrine diseases (Cushing's syndrome, thyroid disease, hypothalamus, pituitary disease, gonadal disease, etc.) or drug treatment (glucocorticoids, antipsychotics);
2. Pregnant and lactating patients, those who have reproductive requirements within the past 6 months or who cannot adequately contraceptive;
3. Combined with mental and intellectual disorders, cardiovascular disease, liver and kidney dysfunction, immune deficiency, diabetes, and blood diseases;
4. Those with contraindications to magnetic resonance scanning, such as non-removable metal dentures, claustrophobia syndrome, etc.;
5. Have a history of surgical treatment of obesity;
6. Patients with long-term dysmenorrhea;
7. Those who have a tendency to bleed, are allergic to alcohol and animal protein and cannot bury the thread.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fMRI data;Body mass index;
Secondary Outcome Measures
NameTimeMethod
Self-rating anxiety scale;Visual analogue appetite scale;Self-rating depression scale;Weight;Waistline;
© Copyright 2025. All Rights Reserved by MedPath